Skip to main content

Table 2 FCGRIIB rs1050501 genotypes and corresponding anti-HSV1 IgG antibody index in AD patients, MCI subjects, and healthy controls

From: Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer’s disease

  FCGRIIB rs1050501 genotypes (%) HSV-1 Ab IgG (AI) HSV-1 IgG1 (OD) HSV-1 IgG2 (OD) HSV-1 IgG3 (OD) HSV-1 IgG4 (OD)
AD (no 69) TT (74.2) 8.94; 7.17–10.50 2.06; 1.47–2.56 0.95; 0.76–1.14 0.65; 0.49–0.78 0.59; 0.58–0.72
CT (22.7) 8.78; 7.22–9.33 2.23; 1.13–2.44 0.75; 0.75–0.75 0.69; 0.49–0.86 0.58; 0.57–1.38
CC (3.1) 7.60; 5.5–9.71 3.18; 3.18–3.18 0.46; 0.46–0.46
MCI (no 52) TT (74.5) 8.82; 7.1–10.96 2.03; 1.68–2.60 0.66; 0.53-0.80 0.75; 0.47-0.95 0.58; 0.56–0.82
CT (21.6) 8.03; 5.25–10.99 2.31; 2.02–3.07 0.61; 0.48–0.77 0.6; 0.57–1.04
CC (3.9) 10.77; 8.85–12.7 2.29; 1.99–2.59 0.44; 0.42–0.47
HC (no 49) TT (79.2) 7.53; 6.12–8.83 2.56; 1.98–2.99 0.62; 0.53–0.72 0.58; 0.54–1.81
CT (18.7) 6.29; 5.60–7.74 2.46; 1.49–2.94 0.89; 0.36–1.17 1.02; 0.68–1.48
CC (2.1) 7.47; 7.47–7.47 3.12; 3.12–3.12 0.55; 0.55–0.55
  1. Data are reported as median; Interquartile range
  2. AD Alzheimer’s disease, MCI Mild Cognitive Impairment, AI antibody index, OD optical density